LJS: Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days

Product code LJS, “Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days” in FDA's classification database, is a Class II device type under 21 CFR 880.5970 (percutaneous, implanted, long-term intravascular catheter), reviewed by FDA's General Hospital panel. FDA's 510(k) database lists 303 clearances under LJS, 98 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
LJS
Regulation
21 CFR 880.5970
Class
II
Panel
General Hospital
Clearances
303
Most recent
Oct 9, 2026
Median review, last 2 years
171 days
Third-party review
Not eligible
Implant
Yes

What it covers

A percutaneous, implanted, long-term intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings, such as luer hubs, and accessories that facilitate the placement of the device. The device allows for repeated access to the vascular system for long-term use of 30 days or more, and it is intended for administration of fluids, medications, and nutrients; the sampling of blood; and monitoring blood pressure and temperature. The device may be constructed of metal, rubber, plastic, composite materials, or any combination of these materials and may be of single or multiple lumen design.

The identification in 21 CFR 880.5970, percutaneous, implanted, long-term intravascular catheter. FDA gives LJS no definition of its own, so the regulation’s describes it.

FDA flags LJS devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K260080Pro-Line XL Power Injectable Central Venous Catheter and Pro-Line XL TunnelerMedical Components, Inc.Oct 9, 2026Traditional
K260929Neonav ECG Tip Location SystemNavi Medical TechnologiesApr 17, 2026Special
K252373BioFlo Hybrid PICC with ENDEXO Technology and PASV Valve Technology; BioFlo PICC with ENDEXO Technology and PASV Valve Technology; BioFlo PICC with ENDEXO Technology; BioFlo Midline Catheter; Xcela Power Injectable PICC; Xcela PICC with PASV Valve Technology; Xcela Hybrid PICC with PASV Valve TechnologySpectrum VascularDec 16, 2025Traditional
K252792PM2™ System with ECGuide™ ConnectorPiccolo Medical, Inc.Nov 17, 2025Special
K243458HydroPICC 4Fr Single Lumen Marked catheter, 130 cm guidewire - Basic Kit (70001301); HydroPICC 4Fr Single Lumen Marked catheter, 70 cm guidewire - Basic Kit (70001302); HydroPICC 4Fr Single Lumen Marked catheter - Maximal Barrier kit (70001304); HydroPICC 5Fr Dual Lumen Marked catheter, 130 cm guidewire - Basic Kit (70002301); HydroPICC 5Fr Dual Lumen Marked catheter, 70 cm guidewire - Basic Kit (70002302); HydroPICC 5Fr Dual Lumen Marked catheter - Maximal Barrier kit (70002304); HydrAccess Vascular, Inc.Aug 1, 2025Traditional
K251212Dual Lumen 5Fr HydroPICC Catheter (PICC-251CM) (PICC-251CM); Dual Lumen 5Fr HydroPICC Catheter (PICC-252CM) (PICC-252CM)Access Vascular, Inc.Jul 1, 2025Special
K243484PM2+ System and SmartPICC StyletPiccolo Medical, Inc.May 29, 2025Traditional
K241587pilot TLSVygon CorporationFeb 26, 2025Traditional
K241910Neonav ECG Tip Location SystemNavi Medical TechnologiesJan 19, 2025Traditional
K243941HydroPICC 4Fr Single Lumen Marked catheter, 130 cm guidewire - Basic Kit (70001201); HydroPICC 4Fr Single Lumen Marked catheter, 70 cm guidewire - Basic Kit (70001202); HydroPICC 4Fr Single Lumen Marked catheter, Maximal Barrier kit (70001204); HydroPICC 4Fr Single Lumen Marked catheter, Mobile Maximal Barrier Kit (90001204)Access Vascular, Inc.Jan 17, 2025Special
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 303 with a free account)

Clearances by year

98 LJS 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)2149
20258171
20241201
2023447
20223177
20213284
20202185
201810148
20177101
20169128
2015771
2014847
20131431
20121477
2011655

Who submits

40 applicants cleared a LJS device since 2011. 97% of the clearances went to applicants in United States, then Australia (2%) and Egypt (1%). By type: Traditional 52%, Special 47% and Abbreviated 1%.

ApplicantClearances since 2011
Navilyst Medical, Inc.13
C.R. Bard, Inc.11
Medical Components, Inc.8
Access Vascular, Inc.6
L&Z Us, Inc.6
Arrow International (Subsidiary of Teleflex Inc.)4
Piccolo Medical, Inc.4
Cook Incorporated3

How FDA classifies it

Class II (special controls) Guidance Document: “Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters.”

From 21 CFR 880.5970. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 880.5970 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LJS clearances declared.

Ask about LJS

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about LJS

What is FDA product code LJS?

Product code LJS, “Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days” in FDA's classification database, is a Class II device type under 21 CFR 880.5970 (percutaneous, implanted, long-term intravascular catheter), reviewed by FDA's General Hospital panel. FDA's 510(k) database lists 303 clearances under LJS, 98 of them since 2011.

How many 510(k) clearances are there under LJS?

FDA’s 510(k) database listed 303 clearances under LJS as of Oct 29, 2026, 98 of them decided since 2011; the most recent decision was Oct 9, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a LJS 510(k)?

For the 10 LJS clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 171 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most LJS clearances?

Since 2011: Navilyst Medical, Inc. (13), C.R. Bard, Inc. (11), Medical Components, Inc. (8), Access Vascular, Inc. (6) and L&Z Us, Inc. (6). 40 applicants have cleared a LJS device in that time.

Sources

  1. FDA product classification: LJS · Product Classification database
  2. 21 CFR 880.5970: Percutaneous, implanted, long-term intravascular catheter · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for LJS · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow LJSGet an email when FDA clears, recalls or publishes guidance for LJS devices.

Know what FDA already cleared.